Gene Query: P2RX5

Dataset Description Geneva Score
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 166.87
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 49.66
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 49.66
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 46.56
Total RNA-seq in ALL-SIL upon JQ1 inhibition 43.07
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 36.28
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 35.19
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 35.19
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 33.79
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 30.76
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 28.95
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 28.59
CircRNAome diversity in human mature B-cells, T-cells and monocytes 27.8
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 27.6
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 27.6
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 26.04
SRSF2 mutations impair hematopoiesis and alter exon recognition 25.6
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 23.07
Landscape of H3K4me3 in human CD19 cells 22.43
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 22.24
The role of FAM46C in myeloma cells [sequencing] 21.68
The role of FAM46C in myeloma cells 21.68
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 21.32
MYCi975 regulates MYC target genes 20.93
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 20.7
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 20.58
snRNAs as regulators of alternative splicing 20.37
Hijacking of stress response machinery by oncogenes in acute leukaemia 20.33
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 20.33
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 20.15
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 19.97
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 19.97
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 18.76
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 18.07
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 18.07
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 17.87
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 17.26
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 17.22
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 16.9
RNAseq of T-ALL upon long non coding rna purturbation 16.69
Intrahepatic MAIT cell gene expression revealed by RNA-seq 16.26
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 15.75
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 15.52
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 15.37
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 14.97
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 14.97
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 14.85
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 14.76
Glioblastoma stem cells infected by ZIKA virus 14.53
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 14.49
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 14.49
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 14.3
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 13.86
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 13.29
Primary Human B-cell Temporal Response to CD40L Stimulation 13.08
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 12.94
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 12.46
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 12.45
Transcriptional changes in lymphoma cells induced by LSD1 depletion 12.34
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 12.34
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 12.2
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 11.84
MYC dependent mRNA translation shapes gene expression and cell biology 11.44
Human T-cell lymphoblastic lymphoma samples and control thymuses 11.37
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 11.37
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 11.09
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 11.09
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 10.69
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 10.49
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 10.43
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 10.2
Transcriptomic analysis of LSD1 10.02
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 9.81
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 9.63
Polarized B -cell functions 9.42
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 9.2
RNA-seq analyisis of PUM2 knockout cells 9.11
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 9.09
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 9.09
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 9.08
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 9.0
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 8.93
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.89
Seletive inhibition of CDK9 in DLBCL cell lines 8.53
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 8.48
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 8.48
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 8.45
Ro60-knockout cells 8.43
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 8.42
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 8.42
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 7.95
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 7.85
Human Treg IL-12 stimulation 7.7
Transcriptome of activated human and mouse MAIT cells 7.65
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 7.61
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 7.58
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 7.44
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 7.42
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 7.38
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 7.33
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 7.29
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 7.24
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 7.17
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 7.15
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 7.1
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 7.07
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 7.04
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 7.04
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 7.0
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 6.93
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 6.9
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 6.82
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 6.82
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 6.72
Microprocessor mediates transcription termination in long noncoding microRNA genes 6.69
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 6.68
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 6.64
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 6.6
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 6.6
The pause-initiation limit restricts transcription activation in human cells 6.6
RNA sequencing with KSHV infection and enrichment for circular RNAs 6.51
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 6.5
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 6.41
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 6.31
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 6.31
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 6.26
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 6.25
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 6.13
Clinker: visualizing fusion genes detected in RNA-seq data 6.11
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 6.11
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 6.07
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 6.05
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 6.02
Gene expression analysis of the impact of TDP-43 knockout in human cells. 5.99
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 5.98
Cajal bodies are linked to genome conformation 5.96
Cajal bodies are linked to genome conformation [RNA-Seq] 5.96
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 5.82
UBC9 knockdown in bladder cancer T24 cell lines 5.73
MeRIP-seq for heat shock in B-cell lymphoma cells 5.69
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 5.69
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 5.67
Trans-differentiation of human adult peripheral blood T cells into neurons 5.63
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 5.51
Bone marrow derived human B cells [normal proB] 5.48
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 5.47
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 5.45
Crizotinib v. DMSO in SW480 cells 5.39
MOF acetyl transferase regulates transcription and respiration in mitochondria 5.36
Accurate annotation of human protein-coding small open reading frames 5.3
Identification of global regulators of T-helper cell lineage specification 5.28
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 5.28
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 5.24
Widespread intronic polyadenylation diversifies immune cell transcriptomes 5.22
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 5.19
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 5.11
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 5.11
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 5.09
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 5.03
Hepatosplenic T cell lymphoma 5.03
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 5.02
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 5.01
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 4.97
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 4.89
A single cell reference map for human blood and tissue T cell activation 4.89
Widespread regulated alternative splicing of single codons accelerates proteome evolution 4.86
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 4.84
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 4.77
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 4.76
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 4.75
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 4.74
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 4.73
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 4.68
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 4.68
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 4.65
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 4.62
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 4.62
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 4.55
ChIP-seq and RNA-seq from human lymphoma cell lines 4.49
RNA-seq data from human lymphoma cell lines 4.49
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 4.47
RNA-seq of resting and activated CD4+ T cells +-JQ1 4.44
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.39
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 4.37
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 4.36
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 4.35
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 4.25
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 4.21
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 4.15
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 4.13
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 4.13
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 4.09
4.09
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 4.01
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 4.0
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 3.98
Transcriptome analysis in Neobractatin treated cells 3.95
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 3.92
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 3.91
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 3.91
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 3.9
Dynamic 3D chromosomal landscapes in acute leukemia 3.9
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 3.84
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 3.81
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 3.8
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 3.77
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 3.77
Epigenetic reprogramming of melanoma cells by vitamin C treatment 3.74
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 3.65
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 3.65
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 3.65
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 3.65
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 3.65
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 3.58
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 3.54
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 3.54
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 3.52
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 3.51
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 3.5
Genome wide miR-191 target profile determined by RIP and gene expression profiling 3.5
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 3.5
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 3.46
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 3.46
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 3.43
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 3.42
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 3.4
Transcriptomes in healthy and CHB fetal hearts 3.39
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 3.39
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 3.39
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 3.37
Gene expression changes due to PARP knockdown in human cells 3.34
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 3.32
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 3.26
The landscape of alternative splicing in aggressive prostate cancers 3.26
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 3.25
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 3.25
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 3.24
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 3.24
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 3.23
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 3.21
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 3.13
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 3.13
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 3.13
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 3.09
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 3.06
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 3.06
Functional significance of the HIV-1 Tat signature amino acid residues 3.05
Dtx3L and Androgen Signaling in Prostate Cancer 3.0
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 2.94
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 2.94
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 2.94
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 2.94
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 2.93
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 2.93
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.92
Genes significantly down or Up-regulated upon RNF219 knockdown 2.91
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 2.9
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 2.9
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 2.9
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 2.9
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 2.89
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 2.89
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 2.87
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 2.85
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 2.84
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 2.82
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 2.8
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 2.8
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 2.8
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 2.79
Genome wide expression change by RNF168 knocking down in MCF-7 cells 2.79
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 2.77
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 2.76
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.68
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 2.65
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 2.65
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 2.65
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 2.64
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 2.61
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 2.61
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 2.6
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 2.59
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 2.51
The evolution of N6-methyladenosine in primates 2.46
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 2.46
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 2.44
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 2.43
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 2.42
Epigenomic conservation of transposable element silencing [RNA-seq] 2.33
Epigenomic conservation of transposable element silencing 2.33
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 2.33
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 2.32
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 2.32
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 2.31
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 2.3
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 2.29
Transcriptome of human white and brown adipose tissue biopsies 2.28
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 2.23
Characterization of human ILC2 subsets 2.21
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 2.16
Landscape and variation of RNA secondary structure across the human transcriptome 2.16
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 2.14
Intron retention induced by microsatellite expansions as a disease biomarker. 2.13
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 2.13
Dysregulated immune system networks in war veterans with PTSD 2.1
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 2.09
hnRNP C is a key regulator of protein synthesis in mitosis 2.09
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 2.07
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 2.03
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 2.02
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 2.01
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 2.01
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 2.01
Be1 and Be2 B cells are transcriptionally distinct 1.98
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 1.97
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 1.94
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 1.94
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 1.94
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 1.91
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 1.9
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 1.9
A Unique Epigenomic Landscape Defines Human Erythropoiesis 1.9
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 1.9
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 1.89
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 1.89
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 1.88
ADAR1-editing of cellular and measles virus-derived duplex RNA 1.85
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 1.85
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 1.85
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 1.83
Primate transcript and protein expression levels evolve under compensatory selection pressures 1.81
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 1.81
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 1.78
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 1.73
Leucegene: ALL sequencing 1.73
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 1.72
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 1.69
Statins modulate endothelial transcriptional profile by inhibiting EZH2 1.69
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.68
Expression and functions of long noncoding RNAs during human T helper cell differentiation 1.67
A novel target of EZH1/2 for treatment of mantle cell lymphoma 1.67
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.66
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 1.64
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 1.63
RNA-Seq and expression data from human adipose tissue 1.61
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 1.61
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 1.6
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 1.6
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 1.6
Transcriptional effect of ETV1 knockdown in melanoma cells 1.58
quanTIseq: quantifying immune contexture of human tumors 1.55
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 1.53
The effect of Abl kinases on non-small cell carcinoma global transcriptome 1.53
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.52
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 1.46
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.46
Expression patterns in chronic thromboembolic pulmonary hypertension 1.45
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 1.44
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 1.42
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 1.41
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 1.41
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.41
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 1.36
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 1.35
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 1.34
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 1.34
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 1.32
RNA sequencing of T-ALL (COG study) 1.32
Analyses of T-ALL (COG study) 1.32
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 1.31
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.3
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.28
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 1.27
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 1.27
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 1.27
Loss of CREBBP results in gene expression repression in lymphoma cells 1.26
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 1.26
Characterization of parental and rociletinib-resistant derived H1975 cell lines 1.25
SOX11 knockdown in B-ALL cell lines 1.25
MHC Transcriptomic landscape at haplotype-specific resolution 1.23
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 1.22
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 1.22
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 1.22
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 1.2
Non-coding regions are the main source of tumor-specific antigens 1.2
Non-coding regions are the main source of tumor-specific antigens [human] 1.2
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 1.16
Total RNA-seq in ALL-SIL upon TLX1 knockdown 1.15
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 1.15
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 1.15
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 1.14
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 1.11
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 1.1
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 1.09
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 1.07
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 1.06
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 1.04
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 1.04
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 1.04
Defective structural RNA processing in relapsing-remitting multiple sclerosis 1.04
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.02
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 1.02
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.0
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 1.0
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 1.0
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 0.99
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 0.99
Identification of long noncoding RNAs in T-ALL cell lines 0.98
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 0.98
Gene expression profile of multiple myeloma cell lines treated with CB-5083 0.97
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.95
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.95
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.91
EWSR1 influences alternative splicing through direct and indirect mechanisms 0.9
Transcriptome-wide identification of CELF2 functional targets in T cells 0.86
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.86
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 0.85
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.85
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.85
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 0.84
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 0.84
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.82
The Genetic Landscape of Diamond-Blackfan Anemia 0.81
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.81
The expression profiles of GBC liver metastasis 0.8
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.77
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.76
Oncogenic roles of ARID5B in T-ALL 0.76
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 0.76
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.75
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.74
naive T cell heterogeneity after neonatal thymectomy 0.74
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 0.73
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 0.73
Total RNA-Seq data from leukemic patients with complex structural variants 0.72
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 0.71
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.69
LncRNA expression profiling of ischemic stroke patients 0.69
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 0.69
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.69
Global response to chemotherapy-induced apoptosis 0.67
Single-Cell Genotyping of Transcriptomes 0.66
RNA-seq of Single-Cell Genotyping of Transcriptomes 0.66
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 0.66
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.66
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.64
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 0.61
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.55
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.54
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.53
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.53
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.52
Genome-wide analysis of the Integrator complex (HTS) 0.5
Genome-wide analysis of the Integrator complex 0.5
Leucegene: AML sequencing (part 6) 0.49
CD74 role in transcription regulation 0.45
CD74 role in transcription regulation [RNA-seq] 0.45
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.44
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 0.44
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.42
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.41
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 0.39
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.35
RNA-Seq of PRMT1 overexpression ECA109 cells 0.35
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.32
Regulation of poly(A) tail and translation during the somatic cell cycle 0.32
JAK dependent survival of ALK- ALCL 0.3
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.3
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 0.29
Proliferation-correlated expression 0.26
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.26
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 0.26
Impact on erythroid progenitor type on erythroid differntiation 0.23
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 0.23
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 0.23
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.23
RNA-seq of CD33 KO and control HSPCs 0.19
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.18
Transcriptional profile in human S. haematobium infection 0.16
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 0.16
CD86 regulates a pro-survival signal in myeloma cells 0.15
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.15
Enhancer activation during EGF response 0.14
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.13
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.13
CDK4/6 inhibitor resistance in prostate cancer 0.13
Downregulation of LATS kinases alters p53 to promote cell migration 0.11
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.08
Transcriptome-wide modulation of splicing by the exon junction complex 0.05
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 0.05
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 0.05
Expression analysis of the TAF1 syndrome 0.05
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 0.04
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.04
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.02
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.02
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.01
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.01
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.0
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation